Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
05/08/2013 | CN103087043A Benzamide derivative resisting proliferative activity and pharmaceutical preparation thereof |
05/08/2013 | CN103086984A 4-phenylamino quinazoline derivative, preparation method and application thereof |
05/08/2013 | CN103086973A Preparation method of terminal alkyne based pyrazol compound |
05/08/2013 | CN103086953A Heterocyclic compound and organic light-emitting device including the same |
05/08/2013 | CN103086949A Carbazole derivatives and organic light emitting diodes comprising the same |
05/08/2013 | CN103086942A Heterocyclic compound and organic light-emitting diode comprising the same |
05/08/2013 | CN102241665B 4-(4,5-dimethoxycarboxyl-1,3-dithiolane-2-yl)benzoyl-L-amino acid benzyl ester as well as synthesis method and applications thereof |
05/08/2013 | CN101821236B Five-membered heterocyclic compound |
05/08/2013 | CN101631778B Cyclopenta [D] pyrimidines as AKT protein kinase inhibitors |
05/08/2013 | CN101578265B Sulfonamide derivatives as chymase inhibitors |
05/08/2013 | CN101218224B Compounds and methods for the treatment or prevention of flavivirus infections |
05/08/2013 | CN101203509B Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity |
05/07/2013 | US8435976 4-substituted pyridin-3-yl-carboxamide compounds and methods of use |
05/07/2013 | CA2694911C Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists |
05/07/2013 | CA2598460C Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
05/07/2013 | CA2575073C Fungicidal composition containing acid amide derivative |
05/07/2013 | CA2551956C Selective estrogen receptor modulators for the treatment of vasomotor symptoms |
05/07/2013 | CA2529154C Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions |
05/02/2013 | WO2013062075A1 Organic electroluminescence element, and material for organic electroluminescence element |
05/02/2013 | WO2013062065A1 Aminoalkyl-substituted n-thienyl benzamide derivative |
05/02/2013 | WO2013062043A1 4-aminocarbazole compound and use of same |
05/02/2013 | WO2013061973A1 Heteroaryl sulfonamide compound or salt thereof |
05/02/2013 | WO2013061850A1 Organic electroluminescence element, display device, and lighting device |
05/02/2013 | WO2013061005A1 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies |
05/02/2013 | WO2013061004A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases |
05/02/2013 | WO2013061002A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases |
05/02/2013 | WO2013060860A1 N-acyl-n'-phenylpiperazine derivatives as srbp modulators for use in the treatment of diabetes and obesity |
05/02/2013 | WO2013060751A1 Novel pyrazine derivatives |
05/02/2013 | WO2013059928A1 Hiv protease inhibitors |
05/02/2013 | WO2013036912A3 Amido compounds as rorϒtmodulators and uses thereof |
05/02/2013 | WO2013033246A9 Novel benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof |
05/02/2013 | US20130109715 6-Substituted isoquinolines and isoquinolinones |
05/02/2013 | US20130109695 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
05/02/2013 | US20130109687 Methods of treating hiv infection: inhibition of dna dependent protein kinase |
05/02/2013 | US20130109652 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
05/02/2013 | US20130108605 Method of ameliorating oxidative stress and supplementing the diet |
05/02/2013 | CA2853688A1 Aminoalkyl-substituted n-thienylbenzamide derivative |
05/02/2013 | CA2852404A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases |
05/02/2013 | CA2851930A1 Novel pyrazine derivatives |
05/02/2013 | CA2849977A1 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies |
05/02/2013 | CA2848263A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases |
05/01/2013 | EP2586778A2 Pyridazinone derivatives useful as glucan synthase inhibitors |
05/01/2013 | EP2585470A2 Novel fused pyrimidine derivatives for inhd3ition of tyrosine kinase activity |
05/01/2013 | EP2585447A2 Compounds and methods for the treatment or prevention of flavivirus infections |
05/01/2013 | EP2585443A1 Process for producing imine compounds for combating invertebrate pests |
05/01/2013 | CN103081155A Light-emitting element |
05/01/2013 | CN103080105A Use of dibenzofurans and dibenzothiophenes substituted by nitrogen-bonded five-membered heterocyclic rings in organic electronics |
05/01/2013 | CN103080104A N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein |
05/01/2013 | CN103080103A Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors |
05/01/2013 | CN103080087A Piperidine derivatives and their use for the treatment of metabolic disorders |
05/01/2013 | CN103080086A Prostaglandin D synthase inhibitory piperidine compounds |
05/01/2013 | CN103079406A Fungicidal pyrazoles |
05/01/2013 | CN101861307B Certain substituted amides, method of making, and method of use thereof |
05/01/2013 | CN101821246B Tetrazole-substituted aryl amide derivatives and uses thereof |
05/01/2013 | CN101365687B Piperazine compounds with a herbicidal action |
04/30/2013 | US8431573 Cyanopyrimidinones |
04/30/2013 | US8431563 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes |
04/30/2013 | US8431250 Aromatic amine derivative, and organic electroluminescent element comprising the same |
04/30/2013 | CA2599425C Substituted gamma lactams as therapeutic agents |
04/30/2013 | CA2595834C Pyrazolylaminopyridine derivatives useful as kinase inhibitors |
04/30/2013 | CA2517256C Aminoheteroaryl compounds as protein kinase inhibitors |
04/25/2013 | WO2013059222A1 2-pyridyloxy-4-nitrile orexin receptor antagonists |
04/25/2013 | WO2013058258A1 Bicyclic heterocyclic compound |
04/25/2013 | WO2013058256A1 Nitrogenated heterocyclic compound, and bactericidal agent for agricultural and horticultural purposes |
04/25/2013 | WO2013057013A2 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
04/25/2013 | WO2013030218A4 Selective and reversible inhibitors of ubiquitin specific protease 7 |
04/25/2013 | WO2012122340A8 Soluble guanylate cyclase activators |
04/25/2013 | US20130102785 Method of making coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling |
04/25/2013 | US20130102619 2-pyridyloxy-4-nitrile orexin receptor antagonists |
04/25/2013 | US20130102602 2-Aryl-4-Quinazolinones And Their Pharmaceutical Compositions |
04/25/2013 | US20130102597 Compounds and methods for treating inflammatory and fibrotic disorders |
04/25/2013 | US20130102592 Oxazole tyrosine kinase inhibitors |
04/25/2013 | US20130102585 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
04/25/2013 | US20130102462 Process for Producing Imine Compounds for Combating Invertebrate Pests |
04/25/2013 | US20130099208 Condensed-cyclic compound, method for preparing the condensed-cyclic compound and organic light-emitting device including the condensed-cyclic compound |
04/25/2013 | US20130099171 Materials for organic electroluminescent devices |
04/25/2013 | CA2852723A1 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
04/25/2013 | CA2852425A1 2-pyridyloxy-4-nitrile orexin receptor antagonists |
04/25/2013 | CA2851589A1 Bicyclic heterocyclic compound |
04/24/2013 | EP2583963A1 Proline analogs as ligands for cannabinoid receptors for the treatment of pain |
04/24/2013 | EP2583956A2 A method of preparation of polycyclic, fused aromatic and heteroaromatic hydrocarbons and intermediates |
04/24/2013 | EP2582695A1 Anthranilic acid diamide derivatives with cyclical side chains |
04/24/2013 | CN1653050B Opioid and opioid-like compounds and uses thereof |
04/24/2013 | CN103068806A 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds |
04/24/2013 | CN103068804A Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators |
04/24/2013 | CN103068798A Di-azetidinyl diamide as monoacylglycerol lipase inhibitors |
04/24/2013 | CN103068797A Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application |
04/24/2013 | CN103058995A Quinazolinyl piperazine derivative and purpose thereof |
04/24/2013 | CN103058987A Condensed-cyclic compound, method for preparing the condensed-cyclic compound and organic light-emitting device including the condensed-cyclic compound |
04/24/2013 | CN103058938A 4-aniline quinazoline compound substituting cinnamic acid, and preparation method and application thereof |
04/24/2013 | CN101863923B Novel inhibitors of chymase |
04/24/2013 | CN101787013B Novel lipoamide derivatives and preparation method and pharmaceutical application thereof |
04/23/2013 | US8426424 Certain substituted amides, method of making, and method of use thereof |
04/23/2013 | CA2634168C Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
04/23/2013 | CA2555712C Novel cyclic compound having 4-pyridylalkylthio group having substituted or unsubstituted amino group introduced therein |
04/23/2013 | CA2552419C Azadecalin glucocorticoid receptor modulators |
04/23/2013 | CA2538906C Process for preparing 4-(4-aminophenyl)-3-morpholinone |
04/23/2013 | CA2471355C Substituted diketopiperazines as oxytocin antagonists |
04/18/2013 | WO2013056015A1 Isoindolinone and pyrrolopyridinone derivatives as akt inhibitors |
04/18/2013 | WO2013055793A1 Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer |